Biotechnology
Healthcare
Technology
The Market Buzz
Scholar Rock Announces Positive Proof-of-Concept Data from Spinal Muscular Atrophy Phase 2 Trial
Scholar Rock Holding Corporation (NASDAQ: SRRK) stock jumped more than 68 percent after the clinical-stage biopharmaceutical company announced positive six-month interim analysis results from the TOPAZ Phase 2 clinical...